Type 2 Diabetes

Contracting COVID-19 is associated with a higher risk for developing new-onset diabetes for men, but not women, according to Department of Veterans Affairs data published in Diabetes Care.

Women with an older age at menopause onset have an increased risk for developing type 2 diabetes, and BMI partially mediates the link between age at menopause and blood glucose levels, according to study findings published in Menopause.

The FDA has approved a once-weekly 2 mg semaglutide injection in conjunction with diet and exercise to lower HbA1c and reduce the risk for cardiovascular events for adults with type 2 diabetes, according to a press release.

Young adults with youth-onset type 2 diabetes developed multiple cardiovascular risk factors during a decade of follow-up, according to an analysis of follow-up data from the TODAY study.

Adults with thyroid eye disease and diabetes have a higher prevalence of diplopia, strabismus and sight-threatening disease compared with those without diabetes, according to study findings published in Endocrine Practice.

Adults who have a mild case of COVID-19 are more likely to develop type 2 diabetes than those who had an acute upper respiratory infection, according to findings from Germany published in Diabetologia.

For patients with type 2 diabetes and COVID-19, the risk for hospitalization increased with incrementally higher HbA1c levels, according to results of a large, multicenter cohort study.

A recent review of electronic health records showed that 4% of adults who were hospitalized with COVID-19 in the beginning of the pandemic were newly diagnosed with diabetes.

A lipid profiling blood test may predict the risk for type 2 diabetes and CVD years in advance, according to findings published in PLOS Biology.

At 10 years, higher baseline levels of systemic inflammatory markers, including plasma interleukin-6 and fibrinogen, were associated with greater cognitive decline for adults with type 2 diabetes, according to data.